ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 485

Different Citrullination Profiles in Spontaneous Versus Leukemia-Associated Rheumatoid Arthritis

Tal Gazitt1, Son Hong Nguyen2, Ari Salinger2, Christian Lood3, Xizhang Sun1, Lena M. Tanaka1, David Feith4, Jeffrey Ledbetter5, Gordon Starkebaum6, Thomas Loughran Jr.7, Paul R. Thompson2 and Keith B. Elkon8, 1Division of Rheumatology, University of Washington, Seattle, WA, 2Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, 3Division of Rheumatology, Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, 4Hematology and Oncology, University of Virginia, Charlottesville, VA, 5University of Washington, Seattle, WA, 6Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 7Hematology Oncology, University of Virginia, Charlottesville, VA, 8Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: citrullination, neutrophils and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Protein citrullination, the post-translational conversion of arginine to citrulline, mediated by peptidylarginine deiminase (PAD) enzymes, is considered a likely mechanism for the stimulation of anti-citrullinated protein antibodies (ACPA) in patients with rheumatoid arthritis (RA).  Hypercitrullination, the citrullination of multiple intracellular proteins, is seen in synovial fluid (SF) cells from RA patients. This unique form of citrullination is proposed to occur via immune-mediated, pore-forming membranolytic pathways such as perforin-granzyme activation.  Indeed, perforin and granzyme-producing CD8+ T effector cells are found in the synovium of pre-clinical RA patients as well as in the peripheral blood (PB) and SF of active RA patients, persisting into disease remission. 

Insight into the existence of potential cytotoxic mechanisms occurring in RA comes from the co-occurrence of RA in up to 36% of cases of T-cell Large Granular Lymphocyte (T-LGL) Leukemia, a clonal condition characterized by neutropenia attributed to the killing of neutrophils or their precursors by cytotoxic CD8+ T cells.   We thus queried LGL leukemia as a model for neutrophil (PMN)-directed cytotoxicity contributing to hypercitrullination and disease propagation in inflamed joints of ACPA+ RA patients. 

Methods:

The sera of 15 T-LGL leukemia patients (T-LGL), 19 T-LGL leukemia patients with co-existing RA (T-LGL/RA), and 4 healthy controls (HC) were analyzed for ACPA positivity by ELISA.  ACPA titers of each group of patients were compared using unpaired two-tailed T tests.  Neutrophils (PMN) from each of these groups were isolated from blood cells by density gradient centrifugation. Hypercitrullination of these cells (n=4/patient group) was compared with that of seropositive RA patients by proteomic analysis using Rhodamine-PG labeling, protein precipitation followed by Streptavidin enrichment, and sequent digestion. The resulting products were analyzed using LC-MS/MS on an LTQ-Orbitrap mass spectrometer. The tandem MS data were searched using SEQUEST algorithm using a concatenated target/decoy variant of the human and mouse International Protein Index database.    

 

Results:

T-LGL/RA patients had significantly higher serum ACPA positivity than T-LGL patients or HC (Fig. 1A). Surprisingly, however, the overall level of citrullinated proteins in PMN (Fig.1B) was not increased in T-LGL/RA compared to T-LGL patients, and was highest in PMN obtained from RA patients (Fig. 1B). 

 

 

 

 

 

 

Conclusion:

These results reveal an interesting dichotomy between RA that occurs spontaneously versus that occurring in patients with LGL leukemia. Whereas both spontaneous and LGL-associated RA develop high titer ACPA, only RA patients show a high degree of citrullination of neutrophil proteins. Whether this suggests a different source of immunogenic proteins or relates to other biologic processes, remains to be determined.   


Disclosure: T. Gazitt, None; S. H. Nguyen, None; A. Salinger, None; C. Lood, None; X. Sun, None; L. M. Tanaka, None; D. Feith, None; J. Ledbetter, None; G. Starkebaum, None; T. Loughran Jr., None; P. R. Thompson, None; K. B. Elkon, Celgene, 5,AstraZeneca, 5,Merck Human Health, 5,Resolve Therapeutic, 4,Amdax Therapeuti, 4.

To cite this abstract in AMA style:

Gazitt T, Nguyen SH, Salinger A, Lood C, Sun X, Tanaka LM, Feith D, Ledbetter J, Starkebaum G, Loughran T Jr., Thompson PR, Elkon KB. Different Citrullination Profiles in Spontaneous Versus Leukemia-Associated Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/different-citrullination-profiles-in-spontaneous-versus-leukemia-associated-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/different-citrullination-profiles-in-spontaneous-versus-leukemia-associated-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology